Filing Details

Accession Number:
0001209191-21-068384
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-12-07 17:41:07
Reporting Period:
2021-11-30
Accepted Time:
2021-12-07 17:41:07
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1826892 Bioatla Inc. BCAB Biological Products, (No Disgnostic Substances) (2836) 851922320
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1835116 Eric Sievers C/O Bioatla, Inc. 11085 Torreyana Road
San Diego CA 92121
Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-11-30 53 $24.00 92,577 No 4 S Direct
Common Stock Disposition 2021-11-30 58 $24.68 92,519 No 4 S Direct
Common Stock Disposition 2021-11-30 20 $25.38 92,499 No 4 S Direct
Common Stock Disposition 2021-12-01 56 $22.19 92,443 No 4 S Direct
Common Stock Disposition 2021-12-01 96 $23.27 92,347 No 4 S Direct
Common Stock Disposition 2021-12-01 21 $24.22 92,326 No 4 S Direct
Common Stock Disposition 2021-12-02 804 $21.74 91,522 No 4 S Direct
Common Stock Disposition 2021-12-02 16 $22.47 91,506 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. Represents shares of the Issuer's common stock sold by the reporting person to cover taxes due upon the release and settlement of the vested RSUs.
  2. The range of prices for the shares of Common Stock is from $23.33 to $24.32. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price.
  3. The range of prices for the shares of Common Stock is from $24.33 to $25.25. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price.
  4. The range of prices for the shares of Common Stock is from $25.30 to $25.38. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price.
  5. The range of prices for the shares of Common Stock is from $21.79 to $22.73. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price.
  6. The range of prices for the shares of Common Stock is from $22.79 to $23.77. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price.
  7. The range of prices for the shares of Common Stock is from $23.80 to $24.68. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price.
  8. The range of prices for the shares of Common Stock is from $21.40 to $22.37. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price.
  9. The range of prices for the shares of Common Stock is from $22.40 to $22.51. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price.